Back to Top Skip to main content Skip to sub-navigation

WRAIR bids farewell to first all-female command team

Two soldiers, wearing masks, passing a flag Army Col. Deydre Teyhen, outgoing commander of Walter Reed Army Institute of Research passes the command's colors to Army Brig. Gen. Michael Talley, commanding general of the Medical Research and Development Command. (Photo courtesy of WRAIR.)

Recommended Content:

Coronavirus

As August comes to an end, Army Col. (Dr.) Deydre Teyhen and Army Command Sgt. Maj. Natasha Santiago close the book on their time as the Walter Reed Army Institute of Research’s commander and command sergeant major.

Leading the DOD’s largest biomedical research laboratory, they presided over a changing institution that works to ensure relevant, fieldable infectious disease and brain health solutions for the Warfighter during Multi-Domain Operations (MDO); more recently, they also oversaw WRAIR’s participation in the whole-of-government coronavirus response. 

“It’s been a unique honor to serve as the 46th commander of WRAIR—and, with Command Sgt. Maj. Santiago, as the first female command team in the institute’s 127-year history,” said Teyhen.

To ensure Service Members are protected from the deployment-related diseases, nearly half of WRAIR’s 2,700-strong workforce is located overseas throughout Southeast Asia, sub-Saharan Africa and the Republic of Georgia.  During their tour, Teyhen and Santiago traveled extensively to visit WRAIR laboratories—both to ensure a strong command presence for overseas staff and to maintain and expand relationships with joint, interagency, intergovernmental and multinational partners.

Two soldiers, wearing masks, passing a flag
Army Brig. Gen. Michael Talley, commanding general of the Medical Research and Development Command passes the command's colors to Army Col. Clinton Murray, incoming commander of Walter Reed Army Institute of Research.  (Photo courtesy of WRAIR.)

Amidst the COVID-19 pandemic, WRAIR dove headfirst into efforts to prevent, detect and treat SARS-CoV-2 with 22 research proposals and nearly $75 million dollars in funded projects.

These efforts include developing a coronavirus vaccine currently scheduled to begin Phase 1 clinical trials in the fall; utilizing artificial intelligence to identify new COVID-19 treatments; advancing new diagnostics tests; screening more than 20,000 soldiers for pandemic-related behavioral health concerns and studying the relationship between sleep and the immune system.

Yet, a rapid pivot and ongoing response to COVID-19 is not the only point of pride from the tenure of Teyhen and Santiago; their command emphasis on relevant and aligned research allowed the institute to pivot to an MDO-driven product development mindset.

Three products that were developed or tested by WRAIR received FDA licensure—tafenoquine, to prevent and cure malaria; intravenous artesunate, to cure severe malaria and Ervebo, a vaccine for Ebola’s Zaire strain—bolstering access to fire-and-forget preventives and effective treatments against infectious disease.

A WRAIR-developed “cocktail” of bacteria-specific viruses, or bacteriophages, was used to save the life of a patient with a multidrug-resistant (MDR) bacterial infection. MDR infections of combat wounds are forecasted to be one of the most pressing threats of MDO as casualties are forced to remain in the field longer with antibiotics made increasingly ineffective due to resistance.

Additionally, WRAIR worked in partnership with the Israel Defense Forces todevelop and began implement iCOVER – a six step, peer-to-peer process for the Warfighter to mitigate acute stress reactions in combat.

Developments continued relating to the negative performance impact of sleep loss and strategies to simplify TBI diagnosis and patient stabilization prior to evacuation.

Santiago is heading to Fort Gordon, Georgia to serve as the command sergeant major for Eisenhower Army Medical Center. Army Sgt. Maj. Rodmond Churchill will be arriving this fall as the incoming command sergeant major. On August 28th, Teyhen will change command with Army Col. Clint Murray, formerly the U.S. Forces Korea surgeon; Teyhen will now serve as the director of the Military Health System Governance for the U.S. Army Office of the Surgeon General in Falls Church, Virginia.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.